Image

Middle East and Africa Persistent Corneal Epithelial Defects Treatment Market – Industry Trends and Forecast to 2030

Pharmaceutical

Image

Middle East and Africa Persistent Corneal Epithelial Defects Treatment Market – Industry Trends and Forecast to 2030

  • Pharmaceutical
  • Upcoming Report
  • Dec 2022
  • MEA
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Middle East and Africa Persistent Corneal Epithelial Defects Treatment Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 18.39 Million
Diagram Market Size (Forecast Year) USD 23.12 Million
Diagram CAGR %

Major Markets Players

  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

Middle East and Africa Persistent Corneal Epithelial Defects Treatment Market, By Clinical Causes (Inflammatory Disease, Neurotrophic Keratitis (NK), Epithelial/Limbal Stem Cell Deficiency, Others), Type (Devices, Medication), End User (Hospital/Clinical Laboratories, Physician Offices, Reference Laboratories and Other End Users), Distribution Channel (Direct Tender, Retail Sales and Other) – Industry Trends and Forecast to 2030.

Middle East and Africa Persistent Corneal Epithelial Defects Treatment Market

Middle East and Africa Persistent Corneal Epithelial Defects Treatment Market Analysis and Size

Persistent corneal epithelial defects treatment market is projected to witness significant growth during the forecast period. Although several therapies exist and an increasing number of novel approaches are evolving, treatment of this disease can still be quite challenging. It is essential to treat the underlying causative condition, which includes infection, limbal stem cell deficiency, or diabetes, to facilitate wound healing. The introduction of the latest technology development that offers numerous therapies for treating several complications caused by the disorder and the increase in incidence of market growth.

Data Bridge Market Research analyses a growth rate in the persistent corneal epithelial defects treatment market in the forecast period 2023-2030. The expected CAGR of persistent corneal epithelial defects treatment market is tend to be around 2.9% in the mentioned forecast period. The market was valued at USD 18.39 million in 2022, and it would grow upto USD 23.12 million by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Middle East and Africa Persistent Corneal Epithelial Defects Treatment Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Clinical Causes (Inflammatory Disease, Neurotrophic Keratitis, Epithelial/Limbal Stem Cell Deficiency, Others), Type (Devices, Medication), End User (Hospital/Clinical Laboratories, Physician Offices, Reference Laboratories and Other End Users), Distribution Channel (Direct Tender, Retail Sales and Other)

Countries Covered

Saudi Arabia, U.A.E, Egypt, Israel South Africa, Rest of Middle East and Africa

Market Players Covered

Dompé farmaceutici S.p.A (Italy), Novartis AG (Switzerland), Abbvie,Inc (U.S.), Johnson & Johnson Services, Inc. (India), Laboratoires Théa. (France), Almirall, S.A (Spain), Ocular Science (U.S.), Kala Pharmaceuticals (U.S.), Bausch Health Companies Inc (Canada), Integra LifeSciences (U.S.), BioTissue (Florida)

Market Opportunities

  • Rise in Eye Surgeries and Contact Lenses
  • Increasing Demand of Treatment Types

Market Definition

Persistent Corneal Epithelial Defects (PCED/ PED) are typically characterized by the failure of rapid re-epithelialization and closure within the range of 10-14 days after a corneal injury, that is combined with standard supportive treatment. This corneal condition results in the disturbance of the corneal surface and the exposed eyes are susceptible to stromal ulceration, scarring, and infections.

Middle East and Africa Persistent Corneal Epithelial Defects Treatment Market Dynamics

Drivers

  • Higher Demand of Hospitals

The increasing demand of hospitals surge the market growth rapidly. Most chronic disease diagnostics are majorly carried out in hospitals as they are very complex and it requires technologically advanced products and thus this is boosting the market for hospital/clinical laboratories.

Opportunities

  • Increase in Eye Surgeries and Contact Lenses

Growing cases of eye surgeries and the higher usage of contact lenses is projected to boost the market growth. For instance, in 2019, Cindy Tromans published a study on “Therapeutic Contact Lenses”. The study expected that a persistent epithelial defect (PED) can have several different etiologies that includes viral or fungal corneal, bacterial infections PED can occur after thermal or chemical burns that leads to slow healing after surgery. Development of novel therapeutics will increase the market and create new opportunities for the growth.

  • Increasing Demand of Treatment Types

Lubricant eye drops are the first line treatment for the PCED treatment, but are usually insufficient to treat PCED. Oxervate is one of the most effective treatment methods for persistent corneal epithelial defects treatment was launched in January 2019, so the acceptability is very low for this product and the pharmaceutical product are more costly compared to device such as Oxervate costs USD 47,200, whereas punctal plug costs nearly USD 27 and bandage contact lens cost about USD 57. Thus, increasing demand for the treatment types boost the market growth.

Restraints/Challenges

  • Lack of skilled professionals

The lack of qualified healthcare professionals who cannot treat the patients with appropriate treatments could reduce the growth of the persistent corneal epithelial defects treatment market over a forecast period.

  • High Cost of Treatment

The vast expenditure required for developing these techniques impede the market growth. Numerous market players make huge investment in manufacturing new and advanced machines to faster the process and in return the cost is increased.

This persistent corneal epithelial defects treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the persistent corneal epithelial defects treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Middle East and Africa Persistent Corneal Epithelial Defects Treatment Market

The persistent corneal epithelial defects treatment market is segmented on the basis of clinical causes, type, end-user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Clinical Causes

  • Inflammatory Disease
  • Neurotrophic Keratitis (NK)
  • Epithelial/Limbal Stem Cell Deficiency
  • Others

Type

  • Devices
  • Medication

End User

  • Hospital/Clinical Laboratories
  • Physician Offices
  • Reference Laboratories
  • Others

Distribution Channel

  • Direct Tender
  • Retail Sales
  • Other

Middle East and Africa Persistent Corneal Epithelial Defects Treatment Market Regional Analysis/Insights

The persistent corneal epithelial defects treatment market is analyzed and market size insights and trends are provided by clinical causes, type, end-user and distribution channel as referenced above.

The major countries covered in the persistent corneal epithelial defects treatment market report are the Saudi Arabia, U.A.E, Egypt, Israel South Africa, Rest of Middle East and Africa.

U.A.E dominates the persistent corneal epithelial defects treatment market because of strong infrastructure base as well as increased consumption of persistent corneal epithelial defects treatments.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Middle East and Africa Persistent Corneal Epithelial Defects Treatment Market Share Analysis

The persistent corneal epithelial defects treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to persistent corneal epithelial defects treatment market

Key players operating in the persistent corneal epithelial defects treatment market  include:

  • Dompé farmaceutici S.p.A (Italy)
  • Novartis AG (Switzerland)
  • Abbvie,Inc (U.S.)
  • Johnson & Johnson Services, Inc. (India)
  • Laboratoires Théa. (France)
  • Almirall, S.A (Spain)
  • Ocular Science (U.S.)
  • Kala Pharmaceuticals (U.S.)
  • Bausch Health Companies Inc (Canada)
  • Integra LifeSciences (U.S.)
  • BioTissue (Florida)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

The persistent corneal epithelial defects treatment market was USD 18.39 million in 2022.
The persistent corneal epithelial defects treatment market is projected to grow at a CAGR of 2.9% during the forecast period of 2023-2030
Middle East and Africa Persistent Corneal Epithelial Defects Treatment Market report is segmented by Clinical Causes, Type, End User, Distribution Channel
U.A.E dominates the persistent corneal epithelial defects treatment market because of strong infrastructure base as well as increased consumption of persistent corneal epithelial defects treatments.
Free Sample Report

CHOOSE LICENCE TYPE

  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials